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Genes within  the I  region of the H-2 gene complex code for two serologically and 
biochemically detectable products mapping in the/-A and LE  subregions (1). The Ia 
molecules are comprised of two noncovalently associated subunits of ~35,000 tool wt 
(alpha chain)  and  26,000-28,000  moi wt  (beta chain).  Ia.7 was the  first  Ia antigen 
marker mapped to the/-E (old/-C) subregion (2) and is a public specificity associated 
with haplotypes k, d,j, p, r, u, v, and w3.  Later, private Ia specificities mapping in the 
/-E  subregion  in  haplotypes  H-2 ~  (Ia.21),  H-2 k  (Ia.22),  and  H-2 a  (Ia.23)  were 
identified  (1, 3, 4). The two-dimensional gel electrophoresis studies of Jones et al. (5, 
6)  has suggested that  the  I-E subregion molecule is  formed by complementation of 
genes mapping in the/-A and/-E subregions. Recent tryptic peptide studies by Cook 
et al.  (7)  showed considerable heterogeneity among the beta chains of I-E molecules 
from recombinants B 10.A(A kEk), B 10.A(5R)  (A bEk), and B 10.S(9R)  (A SEk), whereas 
little  or  no  heterogeneity  was  found  among  the  alpha  chains.  The  above studies 
suggest that I-E molecules are hybrid molecules with a beta chain being coded for by 
a  gene  mapping  in  the  I-A  subregion  (Ea)  and  the  alpha  chain  coded  by a  gene 
mapping in the I-E subregion  (E~). 
The first suggestion of the existence of hybrid/-region determinants was shown by 
Fathman  et  al.  (8,  9)  in  mixed  lymphocyte reaction  (MLR) 1 studies.  They showed 
unique MLR-stimulating determinant on FI cells that were not present on cells from 
either parent. These unique MLR determinants appear to result from the interaction 
of genes controlled by two or more loci within the I region of the H-2 gene complex. 
Recently  studies  by  Schwartz  et  al.  (10)  indicate  that  immune  response  to 
poly(Glu~SLysZ6Phe  9)  (GL~) antigen  may be mediated by unique  hybrid or comple- 
menting  gene  products  coded  by genes  in  the  /-A  and  the  /-E  subregions.  Hence, 
these complementing or hybrid Ia gene products can function as stimulators in MLR 
as well as in immune recognition to specific antigens. 
Although the MLR, immune response, and biochemical studies have suggested the 
existence of unique  hybrid Ia antigens,  no serological evidence has been presented. 
We became interested in the possibility that Ia specificities 22 (E  k) and 23 (E a)  may 
be  determinants  generated  by  hybrid  Ia  molecules,  when  specific  immunizations 
(B10.D2  ×  BI0)F1 anti-B10.A(3R)  and  [B10.A(5R)  ×  D2.GD]F1  anti-B10.D2  failed 
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to  yield anti-Ia.22 and  anti-Ia.23 antibodies after  multiple immunizations. In  this 
study we present serological and biochemical evidence that Ia.22 and Ia.23 are present 
on hybrid Ia molecules from F1 animals but not expressed in either parent. 
Materials and Methods 
Animals.  All mice used in these studies were produced and maintained in our Immunoge- 
netics mouse colony (Mayo Clinic, Rochester, Minn.). We used (BI0 ×  B 10.D2)FI animals for 
the detection of specificity  Ia.22 and [D2.GD  ×  B10.A(5R)]FI  animals for  the detection of 
Ia.23.  H-2 haplotypes of recombinant strains used in this study are noted in Table I. 
Antisera.  The antisera were  produced  in our laboratory as  previously described  (11). To 
detect  Ia.22, the antiserum (C3H.Q X  B10.D2)F1  anti-B10•AQR was  used  in most of these 
studies.  This  antiserum, besides  anti-Ia.22 activity, also  contains activity against  the  I-A ~ 
subregion. However, it is negative with both the parental haplotypes, B10 (H-2 b) and B10.D2 
(H-2 a)  from which the F1 was produced. Specificity and mapping of Ia.22 is defined by the 
•  it  thi  i  w"  b  b  b  b  k  a,d  ~-a  actlv  y  of  s  ant serum  lth  B10.A(3R)  (KA  BJE  C S  D  ).  For  Ia.23  we  used  the 
antiserum (B10.LG  X C3H/Hej)F1  anti-C3H.OL. This antiserum is specific  for  Ia.23.  Even 
though this recipient-donor combination has incompatibility for the I-A  subregion, it has no 
activity against the I-A a-coded antigens. The antiserum is negative on both the parental strains, 
D2.GD and B10.A(5R),  used to produce the F1 animals. As an added cautionary measure the 
anti-Ia.22 was absorbed with B10.A(4R)  (I-A k) to make it specific for Ia.22, and anti-Ia.23 was 
absorbed with  D2•GD  (I-A a)  to make  it  specific  for  Ia.23,  The following antisera were  also 
used: for anti-Ia.22, (B 10 × HTI)FI anti-B  10.A(5R) absorbed with B 10.D2 cells and [B 10.A(4R) 
×  B6]F1 anti-B10.A(2R) absorbed with B10.D2  cells;  for anti-Ia.23, (D2.GD ×  BI0)FI anti- 
B10•BDR-I  absorbed with B10.K and (B10 X A)F1 anti-B10.D2 absorbed with D2.GD. 
C)totoxic  Tests.  Serological  tests  for  the  detection of hybrid Ia antigens were done by a 
microcytotoxic dye-exclusion assay as previously described  (12). The target  cells were  either 
fresh  spleen cells or 72-h cultures of lipopolysaccharide (LPS)-stimulated spleen blasts.  LPS 
blasts were  prepared  as  previously described  (13). In  vitro absorptions were  performed  by 
incubating 250/11 of 1:10 dilution of the antisera with  100 million fresh  spleen cells or LPS 
spleen blasts for  1 h. 
Immunopreczpitation and Sodium Dodecyl Sulfate  (SDS)  Gel Electrophoresis.  Fl and parental LPS- 
stimulated blast cells were prepared by culturing 48-h LPS spleen cells in RPMI-1640 media 
(Grand Island Biological  Co.,  Grand  Island,  N.  Y.)  supplemented with  50 #g/ml  LPS  as 
previously described  (13). The LPS-stimulated blast cells  were  radiolabeled in RPMI-1640 
media without leucine supplemented with glutamine, penicillin (100 U), streptomycin (100 U), 
5% fetal calf serum, and 30 #Ci/ml [:3H]leucine. The LPS blasts were radiolabeled at 37°C in 
a 5% CO2 incubator for  12 h. The radiolabeled cells were then solubilized with 0.50~7~ Triton 
X-100 (Rohm and Haas, Philadelphia, Pa.) in Tris-buffered saline, centrifuged, and the extract 
was then purified by lentil lectin affinity chromatography. The lentil lectin-purified extracts 
were tested with anti-Ia.22 and anti-Ia.23 sera with standard immunoprecipitation and SDS- 
polyacrylamide gel electrophoresis  procedures previously described (14). 
Sequential immunoprecipitations  were done by pretreating radiolabeled extracts overnight 
with either excess normal mouse serum or antiserum, After removal of immune complexes with 
Staphylococcus aureus, the extracts were  divided and subjected to second immunoprecipitations 
overnight with various test  antisera. The antigen-antibody complexes were  removed with 5: 
aureus, and the Ia molecules were anlayzed by SDS gel electrophoresis. 
Results and Discussion 
Serological Identification.  initial cytotoxic studies carried out with fresh spleen cells 
from Fa animals showed only weak reactions• All the cytotoxic tests reported in this 
manuscript was done with LPS-stimulated spleen blasts to enrich for B lymphocytes 
as well as to enhance lysis. Viable blast cells from 48- to 72-h cultures were separated 
from dead cells by layering on Ficoll-Isopaque (Pharmacia Fine Chemicals, Div. of W.  P.  LAFUSE, J.  F.  McCORMICK,  AND C.  S.  DAVID 
TABLE  I 
H-2 Regions of Recombinant Strains Used 
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Strain  Haplotype  K  A  B  J  E  C  S  D  TL 
D2.GD  g2  d  d  b  b  b  b  b  b  b 
BI0.A(5R)  i5  b  b  b  k  k  d  d  d  a 
BI0.A(3R)  i3  b  b  b  b  k  d  d  d  a 
B10.S(9R)  t4  s  s  ?  k  k  d  d  d  a 
BI0.HTT  t3  s  s  s  s  k  k  k  d  c 
B10.LG  arl  d  f  f  f  f  f  f  ?  ? 
C3H.OL  ol  d  d  d  d  d  d  k  k  b 
B10.AQR  yl  q  k  k  k  k  d  d  d  a 
BI0.BDR-1  g4  d  d  d  d  d  d  d  b  b 
BIO  BIO  x  BIO.02. 
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FIG.  1.  Microcytotoxic  reactions ofanti-la.22  [(C3H.Q × BI0.D2)F~ anti-BI0.AQR] against BI0, 
(B 10 × B 10.D2)FI, and B 10.D2 LPS-stimulated spleen lymphocytes. Anti-Ia.8 is a positive control 
[(B10.A × A) anti-B10.A(5R)]. 
Pharmacia, Inc., Piscataway, N. J.). As shown in Fig.  1, LPS spleen blasts from (B10 
×  B10.D2)F1, B10, and B10.D2 were tested with anti-22 sera. The antiserum (C3H.Q 
×  B10.D2)F1 anti-B10.AQR killed -50-60% of the F1  LPS blasts up to a  titer of 1 
in  160,  whereas  no lysis was obtained with  the two parental cells. All three targets 
were uniformly lysed by anti-Ia.8 (I-A). These results indicated that Ia.22 is expressed 
on the hybrid molecules generated by the complementation of A b with E a.  Several 
more F1 combinations and antisera were tested to confirm this observation (Table II). 
A  second F1 combination involving the same haplotype combination (B6  ×  DBA/ 
2)F1  gave  identical results.  An  F1  (D2.GD  ×  B6)  failed  to  show  the  expression of 
Ia.22,  which  suggested  no complementation between Ad-E b.  These  results indicate 
that  expression  of Ia.22  in  B10.A(5R)  is  a  result  of A b and  E k complementation. 
B10.S(9R)  (A'E k)  as  well  as  (B10.S  ×  B10.D2)F1  were  positive  for  Ia.22,  which 
suggested complementation of A S-Ek and A S-Ed.  In the H-2 k haplotype the comple- 
mentation must be between A k and E k. Other combinations, (C3H.O ×  B10.D2)FI 
and  (A.CA ×  B10.D2)Fi, were negative for Ia.22, which suggested noncomplemen- 
tation of Aq-E a and Ar-E a. 
As shown in Fig. 2, both D2.GD and B10.A(5R) LPS spleen blasts are negative for 
Ia.23. Yet, the F1 LPS spleen blasts from [D2.GD ×  B10.A(5R)] gave strong positive 
reactions.  Hence,  Ia.23  can  be  generated  by  the  complementation of Ad with  E k. 
Again, identical expression of Ia.8  (I-A)  was  seen in all  three  targets.  As shown in 
Table II, absorbed anti-Ia.23 sera gave similar results. (D2.GD ×  B6)F1 and (B 10.LG 
×  C3H)Fa did not express Ia.23. These results suggest that Aa-E b and At-E k do not 712  HYBRID  Ia  ANTIGENS 
TABLE  II 
Expression of la.22 and 23* 
Target ce|ls:~ 
C3H.Q x  B6 x  B 10.LG ×  D2.GD × 
B 10.D2§,  B IO.A(4R)  C3HII,  BlOII, anti- 
anti-  §, anti-  anti-  BIO.BDR- 
BI0.AQR,  B10.A(2R),  C3H.OL,  1, 
lAbs.B10.  [Abs.  [Abs.D2.G  [Abs.BlO. 
A(4R)]  B10.D2]  D]  K] 
B10  0  0  --  -- 
BI0.D2  0  0  --  -- 
(B10 ×  BI0.D2)Fj  80  80  -- 
(B6 ×  DBA/2)F]  40  40  --  -- 
(B10.S ×  BI0.D2)F~  80  80  --  -- 
B10.S  0  0  --  -- 
BI0.S(9R)  80  80  -- 
B 10.A(5R)  80  80  0  0 
D2.GD  --  --  0  0 
[D2.GD  x  BI0.A(5R)IF~  --  --  40  40 
B10.P  --  --  0  0 
(D2.GD  x  B10.P)F1  --  --  20  20 
* Reciprocal titers  from microcytotoxic test. 
1: Targets are LPS-stimulated spleen lymphocytes. 
§ Absorbed (Abs.) antisera made specific for Ia.22. 
II Absorbed  antisera made specific for Ia.23. 
D2.GD  D2.GDX  BIO. A  (5R) 
"~  ti-ra. 6  ~  ant|-Ia. 8 
5O 
(0  .23 
.~  30 
I  ,  ..~,-,-.27  1  ,  ,  ,.s 
lO  40  ,e0  320  ,o 
BIO.A  (5R) 
'~ anti-la. 8 
anti  -T: . 23 
40  160  320  10  40  160  320 
Reciprocal of cytotoxic titer 
FIo.  2.  Microcytotoxic reactions  ofanti-la.23 [(BI0.LG × C3H)F] anti-C3H.OL] against  D2.GD, 
[D2.GD  ×  B 10.A(5R)]F1, and BI0.A(5R) LPS-stimulated spleen  lymphocytes. 
complement.  On  the other  hand,  (D2.GD  ×  B10.P)F1  was  positive  for Ia.23,  which 
suggested A a-E  p complementation. 
In an attempt  to test whether  the anti-Ia.22  and  anti-Ia.23  sera were detecting the 
same  hybrid  Ia  determinant  in  the  independent  haplotype  (homologous  ciscomple- 
mentation), recombinant  (nonhomologous ciscomplementation), and in the F] hybrids 
(transcomplementation),  cross-absorptions  were done.  Anti-Ia.22  was  absorbed  with 
B10.K,  B10.A(3R),  and  (B10  ×  B10.D2)FI  LPS  spleen  blasts  and  then  tested  with 
LPS spleen blasts  from these strains as targets.  Each cell type completely absorbed  for 
each other.  Similarly, B 10.D2  and  [D2.GD  X  B 10.A(5R)]F1  cells were used to absorb 
anti-Ia.23 and tested against  both the cell types. Again, complete absorption  was seen. 
These  results  suggest  that  the  antisera  were  detecting  the  same  determinant  in  all 
three types of complementation. 
Biochemical Identification.  To confirm  the expression  of Ia.22  on  (B 10  ×  B 10.D2)F1 
cells and Ia.23 on [D2.GD  ×  B 10.A(5R)] cells, F1 and parental spleen LPS blasts were 
radiolabeled, and the immunoprecipitated  antigens were examined by SDS-polyacryl- 
amide  gel electrophoresis.  As shown  in  Fig.  3,  anti-Ia.22  serum  immunoprecipitated W.  P.  LAFUSE, J.  F.  McCORMICK, AND  C.  S.  DAVID  713 
240 
180 
12(~ 
60 
240 
180 
12(~ 
60 
A  BIO  240 
180 
120 
60 
24O 
D  D2GD 
180 
BIO. D2  240 
180 
120 
6O 
E  BIO. AISR)  240 
180 
C  (BIO  x BIO. D2) F1 
F  [O2GD  ~ BIO.A(SR~]  F~ 
,0 t 
12  24  36  48  12  24  36  48  12  24  36  48 
Gel fraction (2mm) 
FIG.  3.  SDS-poiyacrylamide gel patterns of molecules precipitated with anti-Ia.22  serum, (C3H.Q 
×  B10.D2)FI  anti-Bl0.AQR  (panels  A,  B,  C)  and  anti-la.23  serum,  (BI0.LG  ×  C3H)FI  anti- 
C3H.OL (panels  D,  E, F). In each analysis,  the antigen preparation was from radiolabeled LPS- 
stimulated lymphocytes. 
typical  Ia  peaks  from  the  (B10  ×  B10.D2)Fa  extract  but  not  from  either  B10  or 
B10.D2  extracts.  Similarly anti-Ia.23  serum  immunoprecipitated  Ia molecules from 
[D2.GD ×  B10.A(5R)]F1  extracts but not from D2.GD or B 10.A(5R)  extracts. These 
results  indicate  that  the  cytotoxic  activity of anti-Ia.22  against  (B10  ×  B10.D2)F1 
LPS blasts and anti-Ia.23 against  [D2.GD ×  B10.A(5R)]F1  LPS blasts is due to the 
expression of hybrid Ia molecules on these cells. 
With  F1  mice, two types of I-E molecules are possible. For example, with  (B10  × 
B10.D2)FI,  AaE a  (Ia.23)  molecules  generated  by  ciscomplementation  and  AbE a 
(Ia.22)  molecules  generated  by transcomplementation  are  possible.  Sequential  im- 
munoprecipitations  were  done  to  see  if  both  are  present.  As  shown  in  Fig.  4, 
pretreatment  of (B10  ×  B10.D2)Fa  extracts with excess anti-Ia.23 serum cleared the 
extract of Ia molecules immunoprecipitated by anti-Ia.23 serum, but had no effect on 
molecules  immunoprecipitated  by anti-Ia.22  serum.  This shows  that  there  are  two 
separate I-E molecules in (B 10 ×  B 10.D2)FI. Both of these molecules are Ia, 7 positive, 
because pretreatment with anti-Ia.7 serum cleared for molecules immunoprecipitated 
by anti-Ia.22 and anti-Ia.23 sera. 
The  expression  of Ia.22  on  (B10  ×  B10.D2)F1  cells  most  probably  results  from 
complementation  of  beta  chain  from  A b  and  alpha  chain  from  E a.  This  is  a 
transcomplementation in contrast to the ciscomplementation seen in B10.A(3R)  and 
B 10.A(5R).  Specificity Ia.22 in B 10.A(3R)  and B10.A(5R)  is generated by a comple- 
mentation  between  Ab(E~)  and  E,  k,  rather  than A~(E~)  and E a  shown  here.  Ia.22 
determinant  can  also  be  generated  by transcomplementation  between A~ (Ea)  and 
E a (B 10.S ×  B 10.D2)Fx  or by ciscomplementation between A~ (Ea) and E~  [B 10.S(9R) 
and B 10.HTT]. Ia.23 can be generated by complementation between the beta chain 
of A d and  alpha chain of E k [D2.GD  X  B10.A(5R)]Fa.  Schwartz et al.  (10)  showed 714  HYBRID  la  ANTIGENS 
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FIG.  4.  Sequential immunoprecipitation analysis ofla antigens from a  (B10 ×  BI0.D2)F]  antigen 
preparation. Aliquots were pretreated with normal mouse serum (NMS)  (panels A, B, C): anti-la.23 
serum, (B10.LG ×  C3H)FI  anti-C3H.OL  (panels D,  E,  F);  and anti-la.7 serum (D2.GD  X  B6)F~ 
anti-B10.HTG  (panels G, H, I).  The immune complexes were removed with protein-A-bearing S. 
aureus.  The supernates were  then divided  into  thirds,  and each  third  was  subjected  to  a  second 
precipitation  with anti-la.7 (panels A, D, G), anti-la.23, panels (B,  E, H), or anti-la.22, (panels C, 
F, I). 
that most Ia.7 (I-E)-positive strains can complement with I-A a or I-A b for response to 
GLq~ antigen.  We  tested  a  second  F]  combination  (D2.GD  ×  B10.P)  and  found 
complementation for Ia.23. Studies with other Ia. 7-positive strains are underway. Our 
studies  would  suggest  that  Ia.23  is involved in  the response to GLff antigen.  These 
results suggest  that  Ia.7  is present  on  the alpha chain  coded  by the I-E subregion, 
whereas  Ia.22  and  Ia.23  are  expressed  either  on  the  beta  chain  coded  by the  I-A 
subregions or generated by the hybrid molecule. 
Summary 
Ia specificities 22 and 23 were found to be determinants on hybrid Ia molecules by 
serological and  biochemical studies.  Lipopolysaccharide-stimulated splenic  lympho- 
cytes from (B 10 ×  B 10.D2)F1  expressed Ia.22 although both the parents were negative. 
Similarly  [D2.GD  X  B10.A(5R)]F1  cells  expressed  Ia.23,  whereas  D2.GD  and 
B 10.A(5R)  lacked it. Ia.22 can be generated by gene complementation of A k-Ek, A b 
E d, Ab-E k, A~-E d, and AS-E k, whereas Ia.23 can be generated by Ad-E a, AU-E k, and 
Ad-E p.  Other  possible  complementing combinations  are  under  study.  The  role  of 
Ia.22 and 23 in mixed lymphocyte reactions and immune responses are discussed. W.  P.  LAFUSE, J.  F.  McCORMICK,  AND C.  S.  DAVID  715 
We thank Brian Neely and Paula Woods for expert technical assistance, Suresh Savarirayan for 
superb mouse husbandry, and Sharon Ames for skillful preparation of the manuscript. We also 
thank Dr. David McKean for his advice and use of his laboratory facilities. 
Received for publication  20 November 1979. 
References 
1.  David, C.  S., and S. E. Cullen. 1978. Murine Ia antigens: identification and mapping of 
Ia.23 and further definition of the I-E subregion.J. Immunol.  120:1659. 
2.  David, C. S., S. E. Cullen, and D.  B. Murphy.  1975. Serological and biochemical studies 
with the H-2 gene complex of mice. Further evidence for the I-C subregion.J. Immunol.  114: 
1205. 
3.  Cullen, S. E., D. H. Sachs, and C. S. David. 1976. Use of immune precipitation to identify 
and suggest  mapping position for new Ia specificities.  In Leukocyte Membrane Determi- 
nants Regulating Immune Activity. V.  P.  Eijsvoogel,  D.  Roos,  and W.  P.  Zeijimaker, 
editors. Academic Press, Inc., New York.  507. 
4.  Shreffier,  D. C., C. S. David, S. E. Cullen, J.  A. Frelinger, and J.  E.  Niederhuber.  1977. 
Serological and functional evidence for further subdivision of the I regions of the H-2 gene 
complex. Cold Spring  Harbor Syrup. Quant. Biol.  41"477. 
5.  Jones, P. P., D. B. Murphy, and H. O. McDevitt. 1978. Two gene control of the expression 
ofa murine Ia antigen.J. Exp.  Med.  148"925. 
6.  Jones, P. P., D. B. Murphy, and H. O. McDevitt. 1979. Variability in IA antigen expression. 
Fed. Proc. 38:1280. 
7.  Cook,  R. G., E. S. Vitetta, J. Uhr, andJ. D. Capra.  1979. Structural studies on the murine 
Ia alloantigens. V.  Evidence that  the structural gene for  the I-E/C beta polypeptide is 
encoded within the I-A subregion.J. Exp.  Med.  148:981. 
8.  Fathman, C. G., and M.  Nabholtz.  1977. In vitro secondary MLR.  II. Detection of semi- 
allogeneic (Fl) MLR stimulating determinants. Eur. J. Immunol.  7:370. 
9.  Fathman, C. G., and P. D. Infante. 1979. Hybrid I region antigens and I region restriction 
of recognition in MLR. Immunogenetics.  8:577. 
10.  Schwartz, R. H., A. M. Solinger, M. E. Ultee, E. Margoliash, A. Yano, J.  H. Stimpfling, 
C. Chen, C.  F.  Merryman, P.  H.  Maurer, and W.  E.  Paul. Ir gene complementation in 
murine T-lymphocyte proliferative response.  In  T  and B  Lymphocyte Recognition and 
Function. F. H. Bach, B. Bonavida, and E. S. Vitetta, editors. In press. 
11.  David, C. S., D. C. Shreffler,  and J. A. Frelinger. 1973. New lymphocyte antigen system 
(Lna) controlled by the Ir region at the mouse H-2 complex. Proc. Natl.  Acad.  Sci.  U.  S.  A. 
70:2509. 
12.  Frelinger, J. A., J. E. Niederhuber, C. S. David, and D. C. Shreffler.  1974. Evidence for the 
expression ofIa (H-2-associated)  antigen on thymus-derived lymphocytes.J. Exp. Med.  140: 
1273. 
13.  David, C. S., T. Meo, J. McCormick, and D. C. Shreffler.  1976. Expression of individual 
Ia specificities  on T  and B cells. I. Studies with mitogen-induced blast cells. J.  Exp.  Med. 
143:218. 
14.  Cullen, S. E., and B. D. Schwartz.  1976. An improved method for isolation of H-2 and Ia 
alloantigens with  immunoprecipitation induced by  protein A-bearing staphylococci. J. 
hnmunoL  117:136. 